QMED

QMed, Inc. QMED

Trading inactive

QMED
QMed, Inc. ROIX
Response Oncology, Inc. GNRS
The Greenrose Holding Company Inc. BUGVF
Primo Nutraceuticals Inc. RFCS
Refocus Group, Inc. SYNI
Synvista Therapeutics, Inc. VTEQ
VeriTeQ Corporation LHRP
LifeHOUSE Holdings, LLC

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode QMED ROIX GNRS BUGVF RFCS SYNI VTEQ LHRP
6M -99.00 % 0.00 % -85.71 % 0.00 % -99.99 % 0.00 % 0.00 % 0.00 %
YTD 0.00 % 0.00 % -85.71 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 %
1Y 0.00 % 0.00 % -99.97 % 0.00 % -99.99 % 0.00 % -100.00 % 0.00 %
3Y -99.00 % 0.00 % -100.00 % -99.00 % -100.00 % -99.00 % -100.00 % -99.00 %
5Y -99.00 % -90.00 % -100.00 % -100.00 % -100.00 % -99.67 % -100.00 % -99.00 %
10Y -99.96 % -99.00 % -100.00 % -100.00 % -100.00 % -99.00 % -100.00 % -99.00 %
From the beginning -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.00 %

Dividend